Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters
Psychedelic drug developers rally as Trump orders FDA to expedite reviews Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPRkt5UW9leHZFZmU0NUdRWWNIR3YtM19sNlZQRXduUFFmZWs2NXVXaGdYOTVTelNWQzRkbWU0cHhPU0hFYmw3VlN4VkhnTTJYMUVtZW95U1JvNHk4dUVfWjQ1X0s4XzRwV1JMS2dGZVFFcjZTYXhaelJhZGQ3RkZOLWNqSzdKMFJHcmFSZkNjTTFaVW9hWVZJMkZGM1lUVkxXQWRSRk1DYUU3LWZCdjFtcUh0dTVMM2lYUzE2SzVaSktFaTNtWExJX2cxODc0ZUFp?oc=5" target="_blank">Psychedelic drug developers rally as Trump orders FDA to expedite reviews</a> <font color="#6f6f6f">Reuters</font>
Shares of psychedelic drug developers rose after President Trump signed an executive order directing the FDA to fast-track reviews of psychedelic drugs and increase federal research funding.
President Trump signed an executive order to accelerate research and approval of psychedelic-based therapies, particularly ibogaine, for conditions like PTSD, depression, and addiction.
Shares of psychedelic drug developers rose after President Trump signed an executive order directing the FDA to fast-track reviews of psychedelic drugs and boost federal research funding.
President Trump signed an executive order to speed up access to medical research and treatment based on psychedelic drugs, instructing the FDA to expedite the review of drugs like ibogaine.
Similar Stories
Related coverage based on topic and tags
Trump taps White House adviser Overton to lead FDA - Reuters
Trump taps White House adviser Overton to lead FDA Reuters
August 19, 2026 at 05:03 PMTrump picks White House adviser Heidi Overton to run FDA, source says - Reuters
Trump picks White House adviser Heidi Overton to run FDA, source says Reuters
August 19, 2026 at 12:25 AMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMTrump to host crypto executives as SEC considers regulations - Reuters
Trump to host crypto executives as SEC considers regulations Reuters
August 19, 2026 at 05:40 PMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PM